Funded Tech Companies
Synosia Therapeutics
Wondering who provided funding to Synosia Therapeutics? 5AM Ventures, Versant Ventures and Novo Ventures joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Synosia Therapeutics
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
601 Gateway Boulevard 1200
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
Synosia Therapeutics is a drug development company focused on finding innovative treatments for disorders of the central nervous system (CNS). We are leading a new approach in CNS, establishing a better understanding of a drug's action earlier in development than ever before through small, smart clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/31/2007
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ian Massey
Chief Financial Officer
Philippe Lutz
Chief Medical Officer
Steve Bandak
Vice President
Lesley Pickford
VP - Bus. Development
Tom Woiwode
VP - Finance
Zachary Mcnealy
VP - Operations
Thomas Malefyt
VP - Operations
Ann Neale
VP - R & D
Uwe Meya
VP - Regulatory Affairs
Michael Elson
Company Investors
- 5AM Ventures (Andrew Schwab)
- Versant Ventures (Bradley Bolzon)
- Novo Ventures (Heath Lukatch)
- Abingworth (Andrew Sandham)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs